EMIS Group PLC
LSE:EMIS
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
N/A
N/A
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
EMIS Group PLC
EMIS Group PLC
Cost of Revenue
EMIS Group PLC
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
EMIS Group PLC
LSE:EMIS
|
Cost of Revenue
-£10.9m
|
CAGR 3-Years
18%
|
CAGR 5-Years
6%
|
CAGR 10-Years
0%
|
|
|
Renalytix PLC
LSE:RENX
|
Cost of Revenue
-$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Craneware PLC
LSE:CRW
|
Cost of Revenue
-$27.1m
|
CAGR 3-Years
-71%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-30%
|
|
|
Cambridge Cognition Holdings PLC
LSE:COG
|
Cost of Revenue
-£2.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-17%
|
|
|
Intelligent Ultrasound Group PLC
LSE:IUG
|
Cost of Revenue
-£4m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Doctor Care Anywhere Group PLC
ASX:DOC
|
Cost of Revenue
-£27.6m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-85%
|
CAGR 10-Years
N/A
|
|
EMIS Group PLC
Glance View
EMIS Group Plc engages in the provision of healthcare software and services. The firm operates through two segments: EMIS Health and EMIS Enterprise. Its EMIS Health segment is a supplier of integrated care technology to the National Health Service (NHS), including primary, community, acute and social care. Its EMIS Enterprise segment is focused on growth in the business-to-business (B2B) technology sector within the healthcare market, including management of medicines, partner businesses, life sciences and patient-facing services. The firm operates through its subsidiaries, which include Egton Medical Information Systems Limited, Ascribe Limited and Rx Systems Limited, trading under the EMIS brand; Patient Platform Limited, carrying on the business of Patient.info and Patient Access, and Pinnacle Systems Management Limited, is a provider of service management solutions to the community pharmacy market.
See Also
What is EMIS Group PLC's Cost of Revenue?
Cost of Revenue
-10.9m
GBP
Based on the financial report for Jun 30, 2023, EMIS Group PLC's Cost of Revenue amounts to -10.9m GBP.
What is EMIS Group PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
0%
Over the last year, the Cost of Revenue growth was 30%. The average annual Cost of Revenue growth rates for EMIS Group PLC have been 18% over the past three years , 6% over the past five years .
You don't have any saved screeners yet
